Orbitsymposium 2022

*Please note the schedule is subject to change.

08:00-09:10

Lessons Learned from Challenging Cases

Chairpersons: Sehyun Baek (Korea) Hirohiko Kakizaki (Japan) Diego Strianese (Italy)

08:00-08:07	Frequency of Eschar in Invasive Orbital Fungal Disease	Louise A Mawn (USA)
08:07-08:14	Orbital Mucormycosis in Immunocompetent Patient Following SARS-CoV-2 Vaccination	Diego Strianese (Italy)
08:14-08:21	Intraosseous Orbital Cavernous Hemangioma - Challenges in Its Management	Kasturi Bhattacharjee (India)
08:21-08:28	The Management Approaches to Dacryoceles and Their Orbital Expansion	Pelin Kaynak (Turkey)
08:28-08:35	Nasolacrimal Duct Obstruction in Patient with Meningoencephalocele: An Approach to Have A Successful Surgery	Yunia Irawati (Indonesia)
08:35-08:42	Notorious Masses in and around the Orbit. Cases Discussion	Rohit Saiju (Nepal)
08:42-08:49	Treatment of a Pediatric Case of Orbital Desmoid-type Fibromatosis with Sorafenib	Cat N Burkat (USA)
08:49-08:56	Ophthalmic Manifestations and Visual Outcomes of Granulomatosis with Polyangiitis	Hokyung Choung (Korea)
08:56-09:10	DISCUSSION

09:10-10:25

Thyroid Eye Disease 1 (Medical)

Chairpersons: Helen Lew (Korea) Gangadhara Sundar (Singapore) Raymond Douglas (USA)

09:10-09:20	Thyroid Carcinoma and Thyroid Eye Disease	Lay Leng Seah (Singapore)
09:20-09:35	Teprotumumab in the Treatment of TED	Raymond Douglas (USA)
09:35-09:45	Thyroid Eye Disease with Compressive Optic Neuropathy: Visual Field Loss Classification and Nomenclature	Suzanne K Freitag (USA)
09:45-09:57	Dysthyroid Optic Neuropathy	Peerooz Saeed (Netherlands)
09:57-10:04	Novel Biomarkers in Thyroid Eye Disease	Jin Sook Yoon (Korea)
10:04-10:11	Intraorbital Injections in the Management of TED	Essam El Toukhy (Egypt)
10:11-10:25	DISCUSSION
10:25-10:55	BREAK

10:55-11:45

Thyroid Eye Disease 2 (Surgical)

Chairpersons: Sang-Duck Kim (Korea) Essam El Toukhy (Egypt) Don O Kikkawa (USA)

10:55-11:05	Indication and Functional Outcome of Orbital Decompression in Thyroid Eye Disease	Christoph Hintschich (Germany)
11:05-11:15	Optimizing Outcome of Orbital Decompression using Stereotactic Navigation	Reynaldo Javate (Philippines)
11:15-11:25	Unbalanced Orbital Decompression	Milind Naik (India)
11:25-11:35	Surgical Options for Deep Lateral Wall Decompression	Marco Sales-Sanz (Spain)
11:35-11:45	DISCUSSION

11:45-13:00

Orbital Tumors 2

Chairpersons: Wha-Sun Chung (Korea) Ashok K Grover (India) Geoffrey Rose (UK)

11:45-11:55	Decision Trees in Management of Orbital Malignancy – Towards a Logical Approach to These Tumours	Geoffrey Rose (UK)
11:55-12:05	Five Concepts of Periocular Non-Hodgkin Lymphoma	Jurij R Bilyk (USA)
12:05-12:15	Management of Orbital Perineural Spread of SCC	Dinesh Selva (Australia)
12:15-12:25	Optic Pathway Gliomas: A Non-neurosurgical Approach to Debulking Alone	William R Katowitz (USA)
12:25-12:35	Enlarged One Muscle: What Should We Know?	Kyung In Woo (Korea)
12:35-12:45	Malignant Lacrimal Sac Tumors: Diagnosis and Management	Chieh-Chih Tsai (Taiwan)
12:45-13:00	DISCUSSION
13:00-14:00	LUNCH

14:00-15:40

Lacrimal Gland Malignancy

Chairpersons: Sang In Khwarg (Korea) Santosh G Honavar (India) Bita Esmaeli (USA)

14:00-14:07	Lacrimal Gland Pleomorphic Adenoma and Malignant Epithelial Tumours: Clinical and Imaging Differences	Stephanie Ming Young (Singapore)
14:07-14:17	Pathology of Unusual Malignant Lacrimal Gland Tumors	Steffen Heegaard (Denmark)
14:17-14:27	Considerations for the Treatment of Carcinoma Ex-Pleomorphic Adenoma	James A Garrity (USA)
14:27-14:37	Bascom Palmer Experience with Lacrimal Gland Adenoid Cystic Carcinoma	Wendy Lee (USA)
14:37-14:44	Lacrimal Gland Carcinoma : Why Exenteration Does Not Appear to Improve the Outcome	Geoffrey Rose (UK)
14:44-14:54	Particle Therapy for Adenoid-Cystic Carcinoma of the Lacrimal Gland. Outcome Comparison Between Neutron-, Proton, and Carbon Ion-Therapy.	Eugen B Hug (Austria)
14:54-15:24	Eye-preserving Combined-Modality Treatment for Adenoid Cystic Carcinoma of the Lacrimal Gland	Norbert Liebsch (USA)
15:24-15:40	DISCUSSION
15:40-16:00	BREAK

16:00-17:20

Challenges and Future in the Management of Orbital Diseases

Chairpersons: Sang Yeol Lee (Korea) Chai Teck Choo (Singapore) Peter Dolman (Canada)

16:00-16:10	Endoscopic Removal of Small Optic Apical Cavernous Hemangioma	Wencan Wu (China)
16:10-16:20	360 Degree Circumferential Endoscopic Approaches to the Orbital Apex Lesions	Doo Sik Kong (Korea)
16:20-16:30	Gamma Knife Radiosurgery for Orbital Apical Lesions	Ho Jun Seol (Korea)
16:30-16:40	Orbital Magnets for Intractable Nystagmus: World First	David Verity (UK)
16:40-16:52	Targeted Therapies in Orbital Disease	Timothy Sullivan (Australia)
16:52-17:02	The Use of Immunotherapy for Locally Advanced Orbital and Adnexal Cancers	Bita Esmaeli (USA)
17:02-17:20	DISCUSSION

Orbitsymposium 2020